Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?

Abstract

Singapore would benefit from more frequent studies of clinical HAdV genotypes to identify patients at risk for severe disease and help guide the use of new antiviral therapies, such as brincidofovir, and potential administration of HAdV 4 and 7 vaccine.